Efavirenz/lamivudine/tenofovir

Efavirenz/lamivudine/tenofovir
Combination of
Efavirenz Non-nucleoside reverse transcriptase inhibitor
Lamivudine Nucleoside reverse transcriptase inhibitor
Tenofovir Nucleoside reverse transcriptase inhibitor

Efavirenz/lamivudine/tenofovir is a fixed dose combination medication for the treatment of HIV/AIDS.[1] It combines efavirenz, lamivudine, and tenofovir.[1]

Side effects can include joint pain, sleepiness, headaches, depression, trouble sleeping, and itchiness.[1]

It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[2] A year of medication costs about 154 USD in the developing world.[1]

References

  1. 1 2 3 4 "WHO Model List of Essential Medicines Application" (PDF). WHO. Retrieved 29 June 2017.
  2. ↑ "WHO Model List of Essential Medicines (20th List)" (PDF). World Health Organization. March 2017. Retrieved 29 June 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.